Literature DB >> 15629108

Reaction of ferrous lactoperoxidase with hydrogen peroxide and dioxygen: an anaerobic stopped-flow study.

Walter Jantschko1, Paul G Furtmüller, Martina Zederbauer, Karin Neugschwandtner, Christa Jakopitsch, Christian Obinger.   

Abstract

Lactoperoxidase (LPO) is found in mucosal surfaces and exocrine secretions including milk, tears, and saliva and has physiological significance in antimicrobial defense which involves (pseudo-)halide oxidation. LPO compound III (a ferrous-dioxygen complex) is known to be formed rapidly by an excess of hydrogen peroxide and could participate in the observed catalase-like activity of LPO. The present anaerobic stopped-flow kinetic analysis was performed in order to elucidate the catalytic mechanism of LPO and the kinetics of compound III formation by probing the reactivity of ferrous LPO with hydrogen peroxide and molecular oxygen. It is shown that ferrous LPO heterolytically cleaves hydrogen peroxide forming water and oxyferryl LPO (compound II). The two-electron oxidation reaction follows second-order kinetics with the apparent bimolecular rate constant being (7.2+/-0.3) x 10(4) M(-1) s(-1) at pH 7.0 and 25 degrees C. The H2O2-mediated conversion of compound II to compound III follows also second-order kinetics (220 M(-1) s(-1) at pH 7.0 and 25 degrees C). Alternatively, compound III is also formed by dioxygen binding to ferrous LPO at an apparent bimolecular rate constant of (1.8+/-0.2) x 10(5) M(-1) s(-1). Dioxygen binding is reversible and at pH 7.0 the dissociation constant (K(D)) of the oxyferrous form is 6 microM. The rate constant of dioxygen dissociation from compound III is higher than conversion of compound III to ferric LPO, which is not affected by the oxygen concentration and follows a biphasic kinetics. A reaction cycle including the redox intermediates compound II, compound III, and ferrous LPO is proposed, which explains the observed (pseudo-)catalase activity of LPO in the absence of one-electron donors. The relevance of these findings in LPO catalysis is discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15629108     DOI: 10.1016/j.abb.2004.10.014

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  6 in total

1.  Reactivity of deoxy- and oxyferrous dehaloperoxidase B from Amphitrite ornata: identification of compound II and its ferrous-hydroperoxide precursor.

Authors:  Jennifer D'Antonio; Reza A Ghiladi
Journal:  Biochemistry       Date:  2011-06-15       Impact factor: 3.162

2.  Uric acid and thiocyanate as competing substrates of lactoperoxidase.

Authors:  Antonia Seidel; Heather Parker; Rufus Turner; Nina Dickerhof; Irada S Khalilova; Sigurd M Wilbanks; Anthony J Kettle; Guy N L Jameson
Journal:  J Biol Chem       Date:  2014-06-13       Impact factor: 5.157

3.  Mesna (2-mercaptoethane sodium sulfonate) functions as a regulator of myeloperoxidase.

Authors:  Roohi Jeelani; Seyedehameneh Jahanbakhsh; Hamid-Reza Kohan-Ghadr; Mili Thakur; Sana Khan; Sarah R Aldhaheri; Zhe Yang; Peter Andreana; Robert Morris; Husam M Abu-Soud
Journal:  Free Radic Biol Med       Date:  2017-05-25       Impact factor: 7.376

4.  Hypochlorous acid-induced heme degradation from lactoperoxidase as a novel mechanism of free iron release and tissue injury in inflammatory diseases.

Authors:  Carlos Eduardo A Souza; Dhiman Maitra; Ghassan M Saed; Michael P Diamond; Arlindo A Moura; Subramaniam Pennathur; Husam M Abu-Soud
Journal:  PLoS One       Date:  2011-11-22       Impact factor: 3.240

5.  Enhancing hypothiocyanite production by lactoperoxidase - mechanism and chemical properties of promotors.

Authors:  Jana Gau; Paul-Georg Furtmüller; Christian Obinger; Jürgen Arnhold; Jörg Flemmig
Journal:  Biochem Biophys Rep       Date:  2015-10-09

6.  Pharmacophore-based discovery of 2-(phenylamino)aceto-hydrazides as potent eosinophil peroxidase (EPO) inhibitors.

Authors:  Daniela Schuster; Martina Zederbauer; Thierry Langer; Andreas Kubin; Paul G Furtmüller
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.